UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sumanirole, a highly dopamine D2-selective receptor agonist: in vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson's disease

The Journal of pharmacology and experimental therapeutics, 2005-09, Vol.314 (3), p.1248

2005

Volltextzugriff (PDF)

Dopamine D3 Receptor Antagonists. 1. Synthesis and Structure−Activity Relationships of 5,6-Dimethoxy-N-alkyl- and N-Alkylaryl-Substituted 2-Aminoindans

Journal of medicinal chemistry, 2001-12, Vol.44 (26), p.4716-4732

2001

Volltextzugriff (PDF)

Thienopyrimidine-based P2Y12 platelet aggregation inhibitors

Bioorganic & medicinal chemistry letters, 2009-10, Vol.19 (20), p.5919-5923

2009

Volltextzugriff (PDF)

Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (16), p.4657-4663

2009

Volltextzugriff (PDF)

A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleus

Nature (London), 1990-01, Vol.343 (6255), p.266-269

1990

Volltextzugriff (PDF)

Synthesis and Pharmacological Evaluation of Thiopyran Analogues of the Dopamine D3 Receptor-Selective Agonist (4aR,10bR)-(+)-trans-3,4,4a,10b- Tetrahydro-4-n-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907)

Journal of medicinal chemistry, 2000-07, Vol.43 (15), p.2871-2882

2000

Volltextzugriff (PDF)

Piperazinyl-glutamate-pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation

Bioorganic & medicinal chemistry letters, 2009-11, Vol.19 (21), p.6148-6156

2009

Volltextzugriff (PDF)

Part II: Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation

Bioorganic & medicinal chemistry letters, 2010-02, Vol.20 (4), p.1388-1394

2010

Volltextzugriff (PDF)

Signal transduction pathways modulated by the D2 subfamily of dopamine receptors

Cellular signalling, 1996-09, Vol.8 (6), p.453-459

Huff, R M

1996

Volltextzugriff (PDF)

Sumanirole, a Highly Dopamine D 2 -Selective Receptor Agonist: In Vitro and in Vivo Pharmacological Characterization and Efficacy in Animal Models of Parkinson's Disease

The Journal of pharmacology and experimental therapeutics, 2005-09, Vol.314 (3), p.1248-1256

2005

Volltextzugriff (PDF)

Thiazoloindans and Thiazolobenzopyrans: A Novel Class of Orally Active Central Dopamine (Partial) Agonists

Journal of medicinal chemistry, 2000-09, Vol.43 (19), p.3549-3557

2000

Volltextzugriff (PDF)

Piperazinyl Glutamate Pyridines as Potent Orally Bioavailable P2Y 12 Antagonists for Inhibition of Platelet Aggregation

Journal of medicinal chemistry, 2010-03, Vol.53 (5), p.2010-2037

2010

Volltextzugriff (PDF)

Anti-Inflammatory Properties of CB 1 -Receptor Antagonist Involves β 2 Adrenoceptors

The Journal of pharmacology and experimental therapeutics, 2010-05, Vol.333 (2), p.445-453

2010

Volltextzugriff (PDF)

Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors

European journal of pharmacology. Molecular pharmacology section, 1995-06, Vol.290 (1), p.29-36

1995

Volltextzugriff (PDF)

Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors

Molecular pharmacology, 1994-01, Vol.45 (1), p.51-60

1994

Volltextzugriff (PDF)

Signal transduction pathways modulated by the D 2 subfamily of dopamine receptors

Cellular signalling, 1996-09, Vol.8 (6), p.453-459

Huff, Rita M

1996

Volltextzugriff (PDF)

Piperazinyl Glutamate Pyridines as Potent Orally Bioavailable P2Y12 Antagonists for Inhibition of Platelet Aggregation

Journal of medicinal chemistry, 2010-03, Vol.53 (5), p.2010-2037

2010

Volltextzugriff (PDF)

Thienopyrimidine-based P2Y sub(12) platelet aggregation inhibitors

Bioorganic & medicinal chemistry letters, 2009-10, Vol.19 (20), p.5919-5923

2009

Volltextzugriff (PDF)

Part II: Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y 12 antagonists for inhibition of platelet aggregation

Bioorganic & medicinal chemistry letters, 2010, Vol.20 (4), p.1388-1394

2010

Volltextzugriff (PDF)

Thienopyrimidine-based P2Y 12 platelet aggregation inhibitors

Bioorganic & medicinal chemistry letters, 2009, Vol.19 (20), p.5919-5923

2009

Volltextzugriff (PDF)

Piperazinyl-glutamate-pyrimidines as potent P2Y sub(12) antagonists for inhibition of platelet aggregation

Bioorganic & medicinal chemistry letters, 2009-11, Vol.19 (21), p.6148-6156

2009

Volltextzugriff (PDF)

Behavioral and neurochemical data suggest functional differences between dopamine D 2 and D 3 receptors

European journal of pharmacology, 1994-10, Vol.263 (3), p.235-243

1994

Volltextzugriff (PDF)

Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors

European journal of pharmacology, 1994-10, Vol.263 (3), p.235

1994

Volltextzugriff (PDF)

Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y sub(12) antagonists for inhibition of platelet aggregation

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (16), p.4657-4663

2009

Volltextzugriff (PDF)

Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors

European journal of pharmacology, 1994-10, Vol.263 (3), p.235-243

1994

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(53)
Buchkapitel
(2)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(22)
Humans
(20)
Animals
(19)
Biological And Medical Sciences
(17)
Rats
(13)
Medical Sciences
(11)
Male
(10)
Pharmacology & Pharmacy
(8)
Pharmacology. Drug Treatments
(8)
Cho Cells
(7)
Cricetinae
(7)
Fundamental And Applied Biological Sciences. Psychology
(7)
Antiplatelet
(6)
Antithrombotic
(6)
Cardiovascular Disease
(6)
Female
(6)
Gpcr Antagonist
(6)
Molecular And Cellular Biology
(6)
Neuropharmacology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sumanirole, a highly dopamine D2-selective receptor agonist: in vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson's disease

Dopamine D3 Receptor Antagonists. 1. Synthesis and Structure−Activity Relationships of 5,6-Dimethoxy-N-alkyl- and N-Alkylaryl-Substituted 2-Aminoindans

Thienopyrimidine-based P2Y12 platelet aggregation inhibitors

Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation

A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleus

Synthesis and Pharmacological Evaluation of Thiopyran Analogues of the Dopamine D3 Receptor-Selective Agonist (4aR,10bR)-(+)-trans-3,4,4a,10b- Tetrahydro-4-n-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907)

Piperazinyl-glutamate-pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation

Part II: Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation

Signal transduction pathways modulated by the D2 subfamily of dopamine receptors

Sumanirole, a Highly Dopamine D 2 -Selective Receptor Agonist: In Vitro and in Vivo Pharmacological Characterization and Efficacy in Animal Models of Parkinson's Disease

Thiazoloindans and Thiazolobenzopyrans: A Novel Class of Orally Active Central Dopamine (Partial) Agonists

Piperazinyl Glutamate Pyridines as Potent Orally Bioavailable P2Y 12 Antagonists for Inhibition of Platelet Aggregation

Anti-Inflammatory Properties of CB 1 -Receptor Antagonist Involves β 2 Adrenoceptors

Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors

Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors

Signal transduction pathways modulated by the D 2 subfamily of dopamine receptors

Piperazinyl Glutamate Pyridines as Potent Orally Bioavailable P2Y12 Antagonists for Inhibition of Platelet Aggregation

Thienopyrimidine-based P2Y sub(12) platelet aggregation inhibitors

Part II: Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y 12 antagonists for inhibition of platelet aggregation

Thienopyrimidine-based P2Y 12 platelet aggregation inhibitors

Piperazinyl-glutamate-pyrimidines as potent P2Y sub(12) antagonists for inhibition of platelet aggregation

Behavioral and neurochemical data suggest functional differences between dopamine D 2 and D 3 receptors

Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors

Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y sub(12) antagonists for inhibition of platelet aggregation

Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors

Suchergebnisse filtern